ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag cancer virology cell molecular biology modus operandi techniques

The Right Sort
Richard P. Grant | Aug 1, 2011 | 3 min read
Using the strongest molecular binding partnership in biology to separate different cell types.
obituary, obituaries, roundup, end of the year, COVID-19, SARS-CoV-2, pandemic, coronavirus, immunology, genetics & genomics, cell & molecular biology, HIV
Those We Lost in 2020
Amanda Heidt | Dec 18, 2020 | 7 min read
The scientific community bid farewell to researchers who furthered the fields of molecular biology, virology, sleep science, and immunology, among others.
Telomeres as the Key to Cancer
Jeffrey Perkel | May 26, 2002 | 9 min read
The standard modus operandi for modeling human diseases in the mouse: Find an interesting gene, knock it out, and watch what happens. In theory, the approach makes perfect sense, and scientists have obtained countless subtle insights into the complexities of biology because of it. But mice, of course, are not humans, and many investigators have had to hastily rewrite otherwise elegant theories because of mouse data. One reason? Researchers have taken for granted that telomere length matters. But
a mockup of an at-home COVID-19 test in development
Top Technical Advances of 2020
Shawna Williams | Dec 18, 2020 | 3 min read
The pandemic spurred innovation in a variety of ways, from CRISPR-based diagnostics to cell biology benchwork at home.
The Scientist Staff | Mar 29, 2024
an illustration of Toxoplasma gondii parasites infecting cells
Top Technical Advances of 2019
Shawna Williams | Dec 24, 2019 | 3 min read
From artificial intelligence to pluripotent stem cells, this year saw the publication of a bevy of intriguing new methods, as well as tweaks to existing protocols.
Contributors
Jyoti Madhusoodanan | Oct 1, 2014 | 3 min read
Meet some of the people featured in the October 2014 issue of The Scientist.
Setbacks and Great Leaps
Sue Armstrong | Apr 1, 2015 | 3 min read
The tale of p53, a widely studied tumor suppressor gene, illustrates the inventiveness of researchers who turn mishaps into discoveries.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.

Run a Search

ADVERTISEMENT